EVs and their ‘innate feeling of luxury’ will create a ‘new type of premium,’ says Kia’s top designer25 November 2024
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access ChallengesBy Press Room5 November 2024 Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September.…
Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit UptakeBy Press Room2 April 2024 The Food and Drug Administration approved Winrevair last week. The drug is indicated for a rare and deadly cardiovascular disorder…
House Of Representatives Passes Bill To Ban Use Of QALYs In Federally Funded Healthcare ProgramsBy Press Room9 February 2024 The U.S. House of Representatives passed H.R. 485, the Protecting Health Care for All Patients Act, this week. The bill…